Article PDF
References
Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998;338:853–60.
Lee V, Subak-Sharpe I, Shah S, Aitken C, Limb S, Pinching A . Changing trends in CMV retinitis with triple therapy. Eye 1999;13:59–64.
Vrabec TR, Baldassano VF, Whitecup SM . Discontinuation of maintenance therapy in patients with quiescent cytomegalovirus retinitis and elevated CD4+ counts. Ophthalmology 1998;105:1259–64.
Komanduri KV, Viswanathan MN, Wieder ED, Schimudt DK, Bredt BM, Jacobson MA, McCune JM . Restoration of cytomegalovirus-specific CD4+ T-lymphocyte response after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1. Nature Med 1998;4:953–6.
Pavan PR, O'Donnell JJ, Sattler F, Rao N, Owens S, Pollard R . Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy. Lancet 1997;349:1443–5.
Canzano JC, Reed JB, Morse LS . Vitreomacular traction syndrome following highly active antiretroviral therapy in AIDS patient with cytomegalovirus retinitis. Retina 1998;18:443–7.
Herbort CP, Chave JP . Cicatrization of cytomegalovirus retinitis following introduction of highly active anti-retroviral therapy: uveitis as a possible indicator of good ocular prognosis. Graefes Arch Clin Exp Ophthalmol 1998;236:795–7.
Michelson S, Alcami J, Kim S-J . Human cytomegalovirus infection induces transcription and secretion of transforming growth factor beta 1. J Virol 1994;68:5730–7.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dhillon, B., Ramaesh, K. & Leen, C. Changing trends in cytomegalovirus retinitis with highly active anti-retroviral therapy (HAART). Eye 13, 275–276 (1999). https://doi.org/10.1038/eye.1999.76
Issue Date:
DOI: https://doi.org/10.1038/eye.1999.76